LUMATEInj.
MRP: 285
Packaging: 3 * 2ml
Pack Type: injection
Composition:
α-β Artheether 150mg/2ml
Indication:
Provides quick control on the symptoms of Malaria.
Description:
α-β Arteether 150mg/2ml Injection is a semi-synthetic artemisinin derivative used for the treatment of chloroquine-resistant severe malaria, particularly Plasmodium falciparum infections. It is administered via intramuscular (IM) injection and is effective due to its rapid action on blood-stage malaria parasites.
α-β Arteether is a lipid-soluble compound, offering sustained antimalarial action through slow release, making it suitable for once-daily administration for 3 days. It is often preferred in cases where oral administration is not feasible.
Tags:
- Rapidly kills malaria parasites in the blood
- Long-acting with once-daily dosing
- Useful in resistant P. falciparum infections
- Injectable form for patients unable to take oral meds
- Effective in treating cerebral and complicated malaria
Usage Information
Dosage
Adult Dosage: 150mg (2ml) IM once daily for 3 consecutive days Route: Deep intramuscular injection only Pediatric Use: Dosage adjusted per body weight (typically 3 mg/kg) Note: Shake well before use; do not use intravenously
Side Effects
Pain or swelling at injection site Fever, chills, dizziness Nausea or vomiting Weakness or headache Rare: Neurotoxicity (with prolonged or high-dose use) Allergic reactions (rash, itching, difficulty breathing – rare)
Contraindications
Hypersensitivity to arteether or artemisinin derivatives Do not administer via IV route Avoid in patients with known CNS disorders or seizure history Caution in pregnant women, especially in the first trimester Not for prophylactic use or uncomplicated malaria